Improving the efficacy of antibody-based cancer therapies.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 11905803.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A quarter of a century after their advent, monoclonal antibodies have become the most rapidly expanding class of pharmaceuticals for treating a wide variety of human diseases, including cancer. Although antibodies have yet to achieve the ultimate goal of curing cancer, many innovative approaches stand poised to improve the efficacy of antibody-based therapies.
Medical subject headings
- Antibodies
- Neoplasms